A dysfunctional signaling pathway in the hippocampus has been linked to chronic pain-related memory impairment in mice.

Predicting who will transition from acute to chronic pain is the “holy grail” of pain neuroscience. A novel biomarker ...

Belief is your safe passage—the door through which all healing resides. Why? Because your perception is your reality. Believing in the science of TMS ( tension myositis syndrome) sends a message of ...

Having lived with disabling chronic pain for 32 years, one reader discovered a lesser known treatment that has transformed ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.

Researchers found that mindfulness meditation can modify how a person experiences pain in a way that uses no drugs, proving ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.